Skip to main content
. Author manuscript; available in PMC: 2018 Dec 28.
Published in final edited form as: J Am Coll Cardiol. 2018 Sep 11;72(11):1227–1232. doi: 10.1016/j.jacc.2018.05.075

Table 1:

Patient characteristics by quartile of diastolic blood pressure

Q1:40–64 n=309 Q2:65–71 n=316 Q3: 72–79 n=278 Q4: 80–108 n=356 P-Value
Age, y 75.0 ± 10.5 72.2 ± 10.1 70.6 ± 11.1 67.3 ± 11.0 <0.001
Female, % 35.3 31.0 34.9 26.1 0.030
Race, % 0.084
    White 87.1 91.1 91.7 89.0
    Black 3.6 3.8 3.6 5.9
    Other 9.4 5.1 4.7 5.1
Avoid care due to cost, % 4.9 6.3 6.9 6.2 0.770
High school education, % 32.6 36.1 37.1 35.0 0.684
Heart rate, bpm 68.1 ± 11.7 69.5 ± 11.7 73.2 ± 56.9 70.0 ± 11.1 0.182
Systolic BP, mmHg 117.7 ± 16.3 124.4 ± 14.6 128.8 ± 13.2 139.1 ± 16.0 <0.001
Heart Failure, % 23.0 18.7 17.7 14.6 0.049
Current Smoker, % 6.6 9.6 12.1 12.0 0.077
Hypertension,% 77.0 80.1 79.8 81.7 0.509
Diabetes,% 35.9 39.9 33.9 32.3 0.207
History of stroke/TIA, % 7.4 7.6 7.9 7.6 0.996
History of MI, % 34.0 35.4 45.1 39.3 0.027
Chronic kidney disease, % 17.8 14.2 9.0 9.0 <0.001
BMI, kg/m2 29.6 ± 6.5 30.5 ± 6.4 30.6 ± 6.5 31.3 ± 6.2 0.008
Calcium channel blocker, % 26.9 26.9 21.6 27.5 0.320
Beta blocker, % 77.3 81.0 82.7 76.4 0.166
ACE inhibitor, % 35.3 40.2 38.8 37.4 0.623
ARB, % 27.2 20.9 23.7 26.1 0.259
Diuretic, % 51.1 42.7 36.3 34.6 <0.001
Nitrate, % 58.6 52.5 52.5 46.9 0.028
Ranolazine, % 7.4 6.0 7.9 2.8 0.023
Any angina in past month, % 37.0 33.7 29.9 30.3 0.198
SAQ Angina Frequency 90.0 ±17.5 91.1± 15.1 92.6± 15.3 92.4 ± 15.3 0.143

Values presented as mean ± SD or %. Continuous variables compared using ANOVA. Categorical variables compared using Chi-square.

ACE, angiotensin converting enzyme; ARB, angiotensin receptor blocker; BMI, body mass index; BP, blood pressure; CAD, coronary artery disease; MI, myocardial infarction; SAQ, Seattle Angina Questionnaire; TIA, transient ischemic attack